Yazar "Le, Phuc" için listeleme
-
Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017–March 2020
Le, Phuc; Kaya, Eda; Phan, Anh; Yılmaz, Yusuf; Alkhouri, Naim (Lippincott Williams and Wilkins, 2025)Background: Resmetirom received FDA approval for treating adults with noncirrhotic metabolic dysfunction–associated steatohepatitis (MASH) and moderate-to-advanced liver fibrosis (stages F2–F3). Here, we sought to estimate ...